Avalo Therapeutics (AVTX) Goodwill & Intangibles (2017 - 2025)
Historic Goodwill & Intangibles for Avalo Therapeutics (AVTX) over the last 9 years, with Q3 2025 value amounting to $10.5 million.
- Avalo Therapeutics' Goodwill & Intangibles changed 0.0% to $10.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.5 million for FY2024, which is 0.0% changed from last year.
- As of Q3 2025, Avalo Therapeutics' Goodwill & Intangibles stood at $10.5 million, which was down 0.0% from $10.5 million recorded in Q2 2025.
- Avalo Therapeutics' 5-year Goodwill & Intangibles high stood at $15.6 million for Q1 2021, and its period low was $10.5 million during Q4 2023.
- Moreover, its 5-year median value for Goodwill & Intangibles was $14.4 million (2022), whereas its average is $12.9 million.
- Over the last 5 years, Avalo Therapeutics' Goodwill & Intangibles had its largest YoY gain of 0.0% in 2023, and its largest YoY loss of 2711.5% in 2023.
- Quarter analysis of 5 years shows Avalo Therapeutics' Goodwill & Intangibles stood at $14.4 million in 2021, then dropped by 0.26% to $14.4 million in 2022, then decreased by 27.11% to $10.5 million in 2023, then changed by 0.0% to $10.5 million in 2024, then changed by 0.0% to $10.5 million in 2025.
- Its Goodwill & Intangibles was $10.5 million in Q3 2025, compared to $10.5 million in Q2 2025 and $10.5 million in Q1 2025.